11:20 ET ******
Honeywell International Inc. (HON) 36.27 -0.23: This was a strong start to the year for the industrial company, Honeywell. The Dow component reported organic growth of 6% and expanded profitability in three of four of its businesses. The result topped estimates by two cents earning $359 mln, or $0.42 per share up 24% year/year. Growth was broad-based with the top line expanding by 4.5% year/year to $6.45 bln, vs. the $6.39 bln consensus.
Its business is heavily weighed to the Aerospace and Automation & Control segments accounting for 70% of total sales, as the world’s largest maker of airplane cockpit electronics. On the Aerospace side, sales jumped 9% to $2.5 bln driven by increased parts orders from Boeing and Airbus as global flying hours and the global freight business continued to rise. The Commercial unit gained 12%, while defense and space sales rose 5%. Segment margins swelled 180 basis points to 15.1% on strong volume growth and higher enforcement, both offsetting increased IT spending. During the quarter, HON won a 10-year maintenance agreement worth up to $125 mln from Singapore Airlines. Along with a maintenance and engineering service contract for the F-15 test systems worth more than $450 mln.
Revenue in the Automation & Control unit edged up 2% to $2.0 bln due to a 4% rise in its Life Safety & Security unit. HON completed its acquisition of Novar, the British industrial holding company, on March 31th for which it paid $1.53 bln. It also just announced (4/18) the acquisition of Zellweger Analytics, which manufactures toxic and flammable gas detection systems, expected to close in the second quarter.
Transportation increased 8% to $1.2 bln with its Turbo unit up 14% due to higher diesel penetration in Europe. Its turbochargers used to increase mileage and reduce pollution on gasoline-fuel cars have enjoyed strong growth making up almost half of the new diesel cars sold in Europe. Higher raw material costs offset increased unit volumes keeping margins flat. Co noted it has been “quite successful” in restraining commodity inflation through proactive pricing and productivity gains. The Specialty Materials unit posted a strong quarter. Excluding its divested Performance Fibers business, organic growth rose 5% driven by 11% growth in Chemicals. Price increases and productivity gains were able to counterbalance raw material costs, resulting in segment margins expansion of 180 basis points to 7.4%.
Overall segment profit margins expanded 100 basis points from last year to 11.6%. HON cited strong volume conversion, pricing gains and productivity. The market is hoping operating margins will return to prior peak levels reached in the late 1990’s of 20%+. Honeywell commented on its conference call that an asbestos bill was jointly introduced to the Senate committee last night by Senators Spector and Leahy, which it believes will be a huge step forward in resolving a 20-year national crisis. Litigation costs for asbestos liability lawsuits have weighed on the company for some time.
Looking ahead, HON anticipates sales growth in Q2 of 8-9% to $6.9-7.0 bln, vs. consensus of $6.7 bln. It sees EPS of $0.49-0.51 – roughly in-line with consensus of $0.50 with minimal impact from Novar in the Q2. For FY05, it expects revenues to range between $27.3-27.6 bln above consensus of $26.9 bln as it includes the benefit of the contribution of Novar IBS. It forecasts EPS in the range of $1.95-2.05, which is consistent with its prior guidance, but does expect to come in at the high end, vs consensus of $2.02.
After restructuring its business, which included workforce reductions and streamlining operations, Honeywell is reaping the benefits. The cyclical recovery in the commercial aerospace and industrial industries has provided support and will continue to do so throughout the year. The outlook for the company, as well as shares, looks quite good driven by its strong financial position, revenue acceleration, and earnings momentum. New products, along with accretive acquisitions, and new orders from Airbus will provide further upside going forward. The stock is trading at 18.1x forward earnings near the high end of its historical average. However, the earnings portion of the multiple is likely to expand as the year unfolds. —Kimberly DuBord, Briefing.com
|